Fubao Wang

发表

IgG2m4, an engineered antibody isotype with reduced Fc function

D. Zaller, P. Lu, Gail Forrest, 2009, mAbs.

Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents.

C. Chiu, H. Wilkinson, J. Lineberger, 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody

D. Kimmel, Nan Wei, P. Lu, 2011, Journal of Pharmacology and Experimental Therapeutics.

Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults

D. Mehrotra, J. Shiver, R. Leavitt, 2009, Clinical and Vaccine Immunology.

A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo.

Charles Y. Tan, A. Finnefrock, Victoria Towne, 2010, Human antibodies.

Quantifying the titer and quality of adenovirus stocks.

B. Mathis, J. Wolf, J. Lewis, 2008, Methods in molecular biology.

Generation and Selection of Novel Fully Human Monoclonal Antibodies That Neutralize Dickkopf-1 (DKK1) Inhibitory Function in Vitro and Increase Bone Mass in Vivo

D. Kimmel, Nan Wei, P. Lu, 2010, The Journal of Biological Chemistry.

Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41.

J. Condra, A. Pessi, J. Joyce, 2008, AIDS research and human retroviruses.

A fully human monoclonal antibody to Staphylococcu saureu siro nregulate dsurface determinant B (IsdB) with functional activity i nvitr oan di nvivo

Charles Y. Tan, A. Finnefrock, Victoria Towne, 2010 .

STAT3-induced NCK1 elevation promotes migration of triple-negative breast cancer cells via regulating ERK1/2 signaling

Jinxu Qi, Xinhua Zheng, Fubao Wang, 2021, Molecular Biology Reports.

Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes.

Richard A. Moore, M. Stanley, K. Jansen, 2005, Virology.

Development of an adenovirus-shedding assay for the detection of adenoviral vector-based vaccine and gene therapy products in clinical specimens.

J. Shiver, D. Kaslow, M. Washabaugh, 2003, Human gene therapy.

Characterization of Notch1 Antibodies That Inhibit Signaling of Both Normal and Mutated Notch1 Receptors

K. Ross, J. Aster, K. Stegmaier, 2010, PloS one.

Application of PCR technology in vaccine product development

J. Wolf, Fubao Wang, Liman Wang, 2007, Expert review of vaccines.

Memory T cells and vaccines.

M. Washabaugh, N. Chirmule, L. Tussey, 2003, Vaccine.

Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239

Jiang Fan, Amit Patki, Jason Reed, 2006, Journal of Virology.

Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency.

Charles Y. Tan, B. Mathis, J. Wolf, 2005, Vaccine.

Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

D. Watkins, D. O’Connor, J. Shiver, 2005, Journal of Virology.

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines.

P. S. Bennett, J. Shiver, D. Casimiro, 2004, Human gene therapy.

Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge

D. Watkins, J. Lifson, G. Shaw, 2009, Journal of Virology.

Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A*01-Negative Rhesus Monkeys

J. Shiver, W. Schleif, L. Gabryelski, 2005, Journal of Virology.

Efficacy of Multivalent Adenovirus-Based Vaccine against Simian Immunodeficiency Virus Challenge

D. Watkins, D. O’Connor, J. Shiver, 2009, Journal of Virology.

An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes

N. Geoghagen, L. Mitnaul, D. Johns, 2012, International journal of biological sciences.

A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo1[S]

Lora Hamuro, Jayne Chin, L. Mitnaul, 2011, Journal of Lipid Research.

Distinct expression profiles of Notch-1 protein in human solid tumors: Implications for development of targeted therapeutic monoclonal antibodies

L. Audoly, M. Chastain, A. Bett, 2010, Biologics : targets & therapy.

The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection.

Leslie L. Chavez, A. Perelson, M. Davenport, 2008, Virology.

Surface display of major capsid protein on Bacillus subtilis spores against largemouth bass virus (LMBV) for oral administration.

Youhua Huang, Q. Qin, Quan Wang, 2023, Fish & shellfish immunology.

Optimization of the helper-dependent adenovirus system for production and potency in vivo.

M. Metzker, R. Savino, V. Sandig, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Efficacy of Multivalent Adenovirus-Based Vaccine against Simian Immunodeficiency Virus Challenge

D. Watkins, D. O’Connor, J. Shiver, 2009, Journal of Virology.

Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41

J. Condra, A. Finnefrock, M. Luftig, 2009, mAbs.

modelsorganization analysis in sarcopenia animal Automated rodent in situ muscle contraction assay and

H. Wilkinson, J. Lineberger, Nan Wei, 2015 .